Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008;3(6):669-681.
doi: 10.2217/14796708.3.6.669.

Update on the functional biology of Lrrk2

Heather Melrose  1
Affiliations

Update on the functional biology of Lrrk2

Heather Melrose. Future Neurol. 2008.

Abstract

The etiology of Parkinson's disease (PD) was long thought to be due to environmental factors. Following the discovery of autosomal-dominant mutations in the α-synuclein gene, and later recessive mutations in the DJ-1, Parkin and PINK-1 genes, the field of PD genetics exploded. In 2004, it was discovered that mutations in the PARK8 locus - leucine-rich repeat kinase 2 (LRRK2, Lrrk2) - are the most important genetic cause of autosomal-dominant PD. Lrrk2 substitutions also account for sporadic PD in certain ethnic populations and have been shown to increase the risk of PD in Asian populations. Drug therapies targeting Lrrk2 activity may therefore be beneficial to both familial and sporadic PD patients, hence understanding the role of Lrrk2 in health and disease is critical. This review aims to highlight the research effort concentrated on elucidating the functional biological role of Lrrk2, and to provide some future therapeutic perspectives.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Lrrk2 protein showing predicted domains
Pathogenic substitutions are shown in black and substitutions associated with increase risk shown in white.
Figure 2
Figure 2. MAPKKK domain acids 1800–2138
The kinase active site (green) is centrally located alongside the ATP-binding region (turquoise). The activation segment (magenta) lies between conserved residues DYG and APE. Lrrk2 G2019S and I2020T mutations (indicated by arrow) change highly conserved glycine (G) and isoleucine (I) at the beginning of the activation segment. The activation segment typically blocks substrate access to the catalytic site. (Figure courtesy of J Johnson, Mayo Clinic).
Figure 3
Figure 3. Robust physiological expression of Lrrk2 in a mouse model
Immunoblot to show regional expression of Lrrk2 protein in human BAC transgenic mice using antibody PA0362 (Novus NB110-58771). Expression levels are approximately 20-fold over endogenous mouse Lrrk2.
Figure 4
Figure 4. Lrrk2 is expressed in regions of adult neurogenesis
Lrrk2 is expressed in chains of migrating neuroblasts in the subventricular zone. Red is polysialic acid–neural cell adhesion molecule (PSA-NCAM) a marker for migrating neuronal precursors, green is Lrrk2. Adapted from [94].
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Paisan-Ruiz C, Jain S, Evans EW, et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson’s disease. Neuron. 2004;44:595–600. - PubMed
    1. Funayama M, Hasegawa K, Kowa H, et al. A new locus for Parkinson’s disease (PARK8) maps to chromosome 12p11.2-q13.1. Ann. Neurol. 2002;51:296–301. - PubMed
    1. Zimprich A, Biskup S, Leitner P, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron. 2004;44:601–607. - PubMed

    1. Kachergus J, Mata IF, Hulihan M, et al. Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. Am. J. Hum. Genet. 2005;76:672–680. ▪▪ Demonstrates that LRRK2 G2019S accounts for parkinsonism in several families within Europe and North America and describes an ancestral haplotype indicative of a common founder. In addition, the authors show that penetrance of Lrrk2 G2019S disease is age-dependent and highlights the fact that a proportion of clinically typical, late-onset Parkinson’s disease (PD) cases have a genetic basis.

    1. Funayama M, Hasegawa K, Ohta E, et al. An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family. Ann. Neurol. 2005;57:918–921. - PubMed

LinkOut - more resources